Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- PerkinElmer's COVID-19 test gets emergency use nod for sample poolingon October 29, 2020 at 3:02 pm
PerkinElmer (NYSE:PKI) announces emergency use authorization to allow sample pooling with its New Coronavirus Nucleic Acid Detection Kit, and help increase the number of individuals who can be ...
- Asymptomatic kids With COVID-19 may also carry less viruson October 29, 2020 at 2:23 pm
Most kids infected with COVID-19 who don't have symptoms have low levels of the virus, compared with symptomatic children, a new study finds.
- Covid-19 Breath Analyzer Being Tested At The University Of Miamion October 29, 2020 at 1:33 pm
Currently, the gold standard test for identifying active Covid-19 infection remains a nasopharyngeal swab sample ... very similar to a portable alcohol-detection breathalyzer unit. Breath contains ...
- PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Poolingon October 29, 2020 at 1:14 pm
... New Coronavirus Nucleic Acid Detection Kit has the lowest Limit of Detection (LoD) among the authorized COVID-19 molecular diagnostic tests reported, deeming it the most sensitive assay that ...
- COVID-19 early detectionon October 29, 2020 at 12:29 pm
Fitbit announced today it will receive nearly $2.5 million from the U.S. Department of Defense through the U.S. Army Medical Research and Development Command to expand its work in developing an ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Kontrol Establishes Lower Detection Limit for Commercialization of BioCloudon October 29, 2020 at 8:25 am
"We are pleased to continue to advance towards production of BioCloud units in November," says Paul Ghezzi, CEO Kontrol. "The lower detection limit is an important benchmark to provide potential ...
- Researchers develop autonomous robot to kill SARS-CoV-2on October 28, 2020 at 1:59 pm
"From several studies conducted by my lab over the year, we know that commonly used UV irradiation is effective in inactivating or neutralizing SARS-CoV-2, and virus inactivation depends not only ...
- Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panelon October 28, 2020 at 3:30 am
PRNewswire/ -- Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of ...
- Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Markon October 26, 2020 at 5:03 pm
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for ...
- BioCanna Announces A Breakthrough In Development of Its Patent-Pending ‘BioNano Virus Detection System’ And Announcing the COVID-19 POC Test Kiton October 26, 2020 at 8:30 am
BioCanna Health Care Inc., a leading innovator in pharmaceutical applications of Cannabinoids, Terpenes and other biomaterials, has announced that its wholly owned subsidiary, BioCanna CuraLab, in ...